Kollef, Marin H.

Inadequate Antimicrobial Treatment of Infections

Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest

Antibiotic Use and ResistanceNosocomial Infections in ICU

Cited by 1,805

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest

Antibiotic Use and ResistanceSepsis Diagnosis and Treatment

Cited by 1,779

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)

Torres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal

Nosocomial Infections in ICUAntifungal resistance and susceptibility

Cited by 1,387

Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 1,286

Prevalence and outcomes of infection among patients in intensive care units in 2017.

Vincent, J.-L., Sakr, Y., Singer, M., Martin-Loeches, I., Machado, F. R., Marshall, J. C., Finfer, S., Pelosi, P., Brazzi, L., Aditianingsih, D., et al. (2020) · JAMA

Nosocomial Infections in ICUSepsis Diagnosis and Treatment

Cited by 1,011

Epidemiology and Outcomes of Health-care–Associated Pneumonia

Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest

Nosocomial Infections in ICUPneumonia and Respiratory Infections

Cited by 948

Septic shock attributed to Candida infection: Importance of empiric therapy and source control.

Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A. (2012) · Clinical Infectious Diseases

Antifungal resistance and susceptibilitySepsis Diagnosis and Treatment

Cited by 477

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 192

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Tabah, A., Bassetti, M., Kollef, M. H., Zahar, J.-R., Paiva, J.-A., Timsit, J.-F., Roberts, J. A., Schouten, J., Giamarellou, H., Rello, J., et al. (2020) · Intensive Care Medicine

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 191

Duration of exposure to antipseudomonal β-lactam antibiotics in the critically ill and development of new resistance.

Teshome, B. F., Vouri, S. M., Hampton, N., Kollef, M. H., & Micek, S. T. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 190

Treatment-related risk factors for hospital mortality in Candida bloodstream infections

Labelle, A. J., Micek, S. T., Roubinian, N., & Kollef, M. H. (2008) · Critical Care Medicine

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 181

Implementation of a real-time computerized sepsis alert in nonintensive care unit patients*

Sawyer, A. M., Deal, E. N., Labelle, A. J., Witt, C., Thiel, S. W., Heard, K., Reichley, R. M., Micek, S. T., & Kollef, M. H. (2011) · Critical Care Medicine

Sepsis Diagnosis and TreatmentHealthcare Technology and Patient Monitoring

Cited by 169

Early palliative care consultation in the medical ICU: A cluster randomized crossover trial.

Ma, J., Chi, S., Buettner, B., Pollard, K., Muir, M., Kolekar, C., Al-Hammadi, N., Chen, L., Kollef, M., & Dans, M. (2019) · Critical Care Medicine

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 166

Timing of antibiotic therapy in the ICU

Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J.-F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021) · Critical Care

Antibiotics Pharmacokinetics and EfficacySepsis Diagnosis and Treatment

Cited by 161

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment.

Schramm, G. E., Johnson, J. A., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2006) · Critical Care Medicine

Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

Cited by 145

Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients*

Micek, S. T., Anand, N. J., Laible, B. R., Shannon, W. D., & Kollef, M. H. (2005) · Critical Care Medicine

Intensive Care Unit Cognitive DisordersAnesthesia and Sedative Agents

Cited by 141

Secular trends in candidemia-related hospitalization in the United States, 2000–2005

Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Infection Control & Hospital Epidemiology

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 137

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

Zilberberg, M. D., Kollef, M. H., Arnold, H., Labelle, A., Micek, S. T., Kothari, S., & Shorr, A. F. (2010) · BMC Infectious Diseases

Antifungal resistance and susceptibilityAntibiotic Use and Resistance

Cited by 128

Targeted Fluid Minimization Following Initial Resuscitation in Septic Shock

Chen, C., & Kollef, M. H. (2015) · Chest

Sepsis Diagnosis and TreatmentHemodynamic Monitoring and Therapy

Cited by 92

Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections.

Burnham, J. P., Olsen, M. A., Stwalley, D., Kwon, J. H., Babcock, H. M., & Kollef, M. H. (2018) · Open Forum Infectious Diseases

Antibiotic Use and ResistanceSepsis Diagnosis and Treatment

Cited by 90

A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia

Shorr, A. F., Myers, D. E., Huang, D. B., Nathanson, B. H., Emons, M. F., & Kollef, M. H. (2013) · BMC Infectious Diseases

Antimicrobial Resistance in StaphylococcusPneumonia and Respiratory Infections

Cited by 84

An integrated data mining approach to real-time clinical monitoring and deterioration warning

Mao, Y., Chen, W., Chen, Y., Lu, C., Kollef, M., & Bailey, T. (2012) · Proceedings of the 18th ACM SIGKDD international conference on Knowledge discovery and data mining

Healthcare Technology and Patient MonitoringArtificial Intelligence in Healthcare

Cited by 76

Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia.

Cowley, M. C., Ritchie, D. J., Hampton, N., Kollef, M. H., & Micek, S. T. (2019) · Chest

Nosocomial Infections in ICUAntibiotic Use and Resistance

Cited by 49

Culture-negative sepsis.

Thorndike, J., & Kollef, M. H. (2020) · Current Opinion in Critical Care

Sepsis Diagnosis and TreatmentAntibiotic Use and Resistance

Cited by 42